MS – Erectile Dysfunction Treatment — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Phosphodiesterase-5 inhibitor (e.g. sildenafil)
Erectile dysfunction is a common non-motor symptom in MS, caused by spinal cord demyelination affecting autonomic pathways. NICE NG100 recommends PDE-5 inhibitors (sildenafil, tadalafil) as first-line treatment for erectile dysfunction in MS, after excluding other causes (hormonal, vascular, psychological, drug-related). They are effective in approximately 70–80% of MS patients with ED. A: Intracavernosal injection is second-line if PDE-5 inhibitors fail. C: Testosterone replacement is only indicated if testosterone is low. D: Vacuum devices are an alternative. E: Prosthesis is last resort.
Reference: NICE NG100 MS (2022); NICE CG76 Sexual Dysfunction in Men